On May 1, Sarah Butler, chief commercial officer at ADVI Health, sat down with Pharmacy Times to discuss the potential impact of the Inflation Reduction Act (IRA) on drug prices and patient access, emphasizing the need for pharmacists to educate patients on changes like copay smoothing. She also touched on how the upcoming election may impact health policies, including the IRA.

You can read more of Sarah’s insights in Pharmacy Times.